全球病毒过滤市场规模：地区、范围和预测

病毒过滤市场规模及预测

2024 年病毒过滤市场规模为 45.2612 亿美元，预计到 2031 年将达到 107.1203 亿美元，2024 年至 2031 年复合年增长率为 11.37%。

病毒过滤的全球市场推动因素。

病毒过滤市场的市场推动因素可能受到多种因素的影响。

促进生物製药生产：

高效的病毒过滤技术对于维持生物製品（包括单株抗体、疫苗和治疗性蛋白质）的安全性和纯度是必要的。

慢性病增加：

由于癌症、糖尿病和自体免疫疾病等慢性疾病的增加，对生物製药的需求不断增加。因此，对病毒过滤器以保持这些药物的完整性的需求不断增加。

严格的监理准则：

FDA 和 EMA 等监管机构对生物製药生产中病毒的安全性制定了严格的规定。遵守这些标准需要先进的病毒过滤技术。

技术进步

高容量过滤器和先进的过滤系统是病毒过滤创新的例子，它们提高了效率和可靠性，对生物製药企业更具吸引力。

扩大研发投入：

推动市场的关键因素之一是生物製药公司增加研发支出，以开发新的和增强的病毒过滤技术。

生技产业的成长：

生物技术领域正在迅速扩大，特别是在发展中国家，对与病毒过滤相关的服务和产品的需求正在增加。

关注仿製药和生物相似药：

对病毒过滤技术的需求是由生物相似药和仿製药市场不断扩大所推动的。这些需要与原始生物製剂的品质相称的严格的病毒过滤程序。

病毒污染髮生率增加：

对生物药物病毒污染的认识和担忧促使越来越多地使用病毒过滤作为基本的安全预防措施。

一次性使用科技的接受度：

病毒过滤市场正在扩大，因为生物製药製造倾向于一次性系统，因为一次性系统成本低且交叉污染风险低。

零件製造组织 (CMO) 的发展：

CMO 在生物製药製造过程中的重要性日益增加，增加了对满足客户各种需求的卓越病毒过滤解决方案的需求。

全球病毒过滤市场的阻碍因素

有几个因素可能会成为病毒过滤市场的限制和挑战。其中包括：

过滤系统成本高：

病毒过滤系统及相关耗材成本高昂，导致中小型企业难以购买。这种高昂的初始费用可能是实施和广泛使用的主要障碍。

先进且严格的监理需求：

生物製药产业受到严格监管，在病毒过滤方面有严格的规定，以确保产品安全。遵守这些法规既耗时又昂贵，并且可能会延迟产品开发和市场开发。

技术难度：

理论上很难创建一个高效的病毒过滤系统，能够处理各种类型的病毒而不降低产品品质或生产率。这种复杂性可能会延迟新过滤方法的开发和应用。

熟练劳动力限制：

病毒过滤系统的操作需要特定的知识和能力。缺乏监督此类复杂系统的熟练人员可能会阻碍该领域的扩展。

供应链问题：

用于病毒过滤的设备和耗材容易受到供应链的影响。流行病、自然灾害和不稳定的地缘政治局势等事件可能导致关键零件和资源的短缺。

竞争环境：

病毒过滤器市场竞争极为激烈，老牌公司占据主导地位。凭藉强大的市场影响力和众多忠实客户，这些历史悠久的公司可能很难让新进入者与之竞争。

经济衰退：

生物製药产业的研发资金可能会受到经济波动和衰退的影响。资金减少可能会导致对新病毒过滤技术和技术的投资减少。

目录

第1章全球病毒过滤市场简介

• 市场概览
• 调查范围
• 先决条件

第 2 章执行摘要

第3章研究方法

• 资料探勘
• 验证
• 主要来源
• 资料来源列表

第4章全球病毒过滤市场展望

• 摘要
• 市场动态
  • 促进因素
  • 抑制因素
  • 机会
• 波特的五力模型
• 价值链分析
• 监理框架

第5章全球病毒过滤市场（按应用）

• 医疗设备
• 纯水
• 空气净化
• 生物製品
  • 疫苗和治疗药物
  • 血液和血液製品
  • 细胞/基因治疗产品
  • 其他

第 6 章全球病毒过滤市场：依产品

• 试剂盒和试剂
• 过滤系统
• 服务
• 其他产品

第 7 章全球病毒过滤市场：依最终使用者划分

• 製药和生技公司
• 合约研究组织
• 学术研究所
• 医疗器材公司

第 8 章全球病毒过滤市场：依地区划分

• 摘要
• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 阿根廷
• 世界其他地区

第9章全球病毒过滤市场竞争格局

• 摘要
• 各公司的市占率
• 供应商情况
• 主要发展策略

第10章公司简介

• Merck & Co.
• GE Healthcare
• Thermo Fisher Scientific, Inc.
• Lonza Group Ltd.
• Sartorius AG
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec
• Pall Corporation
• Charles River Laboratories

第11章 附录

• 关联调查

Virus Filtration Market Size And Forecast

Virus Filtration Market size was valued at USD 4526.12 Million in 2024 and is projected to reach USD 10712.03 Million by 2031 , growing at a CAGR of 11.37% from 2024 to 2031. Global Virus Filtration Market Drivers The market drivers for the Virus Filtration Market can be influenced by various factors. These may include: Boosting the Production of Biopharmaceuticals: Efficient viral filtration techniques are necessary to preserve the safety and purity of biologics, which include monoclonal antibodies, vaccines, and therapeutic proteins, due to the growing demand for these products.

Increasing Rate of Chronic Illnesses:

The demand for biopharmaceutical goods has increased because to the rise in chronic diseases like cancer, diabetes, and autoimmune disorders. This has resulted in a greater requirement for viral filtering to preserve the integrity of these medicines.

Tight Regulating Guidelines:

Strict regulations are in place for viral safety in the manufacturing of biopharmaceuticals from regulatory organisations including the FDA and EMA. Advanced viral filtration technologies are required in order to comply with these criteria.

Technological Progress:

High-capacity filters and sophisticated filtration systems are examples of virus filtration innovations that have improved efficiency and dependability, making them more appealing to biopharmaceutical businesses.

Growing R&D Investment:

One important factor driving the market is biopharmaceutical firms' increased expenditure in R&D to create novel and enhanced viral filtration techniques.

Growth of the Biotechnology Industry:

The biotechnology sector is expanding quickly, especially in developing nations, which increases the need for services and goods related to viral filtering.

Pay Attention to Generics and Biosimilars:

The demand for virus filtration technologies is driven by the expanding market for biosimilars and generic biologics, which need strict virus filtration procedures to match the quality of original biologics.

Growing Viral Contamination Incidence:

The use of virus filtration as an essential safety precaution has expanded due to awareness of and worry over viral contamination in biopharmaceutical products.

Acceptance of One-Time Use Technologies:

The market for viral filtration is expanding due to the tendency in biopharmaceutical manufacturing towards single-use systems because of their low cost and lower danger of cross-contamination.

Component Manufacturing Organisations (CMOs) are Growing:

The need for superior virus filtering solutions to satisfy a range of customer demands is fueled by the growing significance of CMOs in the biopharmaceutical production process.

Global Virus Filtration Market Restraints

Several factors can act as restraints or challenges for the Virus Filtration Market. These may include:

High Filtration System Cost:

The cost of virus filtration systems and related consumables makes it difficult for small and medium-sized businesses to afford them. This expensive initial outlay may act as a major deterrent to adoption and admission.

Sophisticated and Tight Regulatory Needs:

The biopharmaceutical sector is heavily regulated, and strict rules for viral filtering are in place to guarantee the safety of the products. It may take a while and be expensive to comply with these rules, which could postpone product development and market launch.

Technology Difficulties:

It is theoretically difficult to create efficient viral filtering systems that can handle different kinds of viruses without lowering the product's quality or production. The development and application of new filtration methods may be slowed down by these complications.

Restricted Skilled Labour:

Systems for filtering viruses require specific knowledge and abilities to operate. The insufficiency of skilled personnel to oversee these intricate systems can impede the expansion of the sector.

Problems with the supply chain:

Equipment and consumables used in viral filtration have a susceptible supply chain. Critical parts and resources may become scarce due to events like pandemics, natural disasters, or unstable geopolitical conditions.

Competitive Environment:

The market for viral filtering is extremely competitive, with well-established companies holding a dominant position. Due to their strong market presence and devoted clientele, these well-established businesses may be tough for newcomers to compete with.

Economic Recessions:

Funding for research and development in the biopharmaceutical industry may be impacted by economic volatility or recession. Decreased funding may result in less money being invested on novel viral filtration techniques and technologies.

Global Virus Filtration Market Segmentation Analysis

The Global Virus Filtration Market is segmented on the basis of Type, Application, End-User, And Geography.

Virus Filtration Market, By Type

• Kits and Reagents
• Services
• Filtration Systems
• Others

Based on Type, the market is segmented into kits and reagents, services, filtration systems, and others. Kits and Reagents accounted for the largest market share in 2021, and is projected to grow at a CAGR of 11.72% during the forecast period. The reagents help identify viruses that may contaminate the cell substrate or other reagents or materials used in the evaluation process. Qiagen and Merck Millipore are two well-known manufacturers of reagents and kits for virus filtration. Blood, plasma, serum, bodily fluids, and any monoclonal antibody and recombinant proteins are used in the production of biopharmaceuticals.

Virus Filtration Market, By Application

• Medical Devices
• Water Purification
• Air Purification
• Biologicals
• Vaccines and Therapeutics
• Blood and Blood Products
• Cellular and Gene Therapy Products
• Others

Based on Application, the market is segmented into medical devices, water purification, air purification, and biologicals. Biologicals accounted for the largest market share in 2021, and is projected to grow at the highest CAGR of 12.08% during the forecast period. Biologicals are being used to treat and correct a wide range of medical situations and metabolic dysfunctions. Virus removal methods involve size exclusion, including filtration, adsorption to specific matrices, including chromatography, and partitioning into a different fraction. Filtration methodologies designed for viral removal applications considerably contribute to a reduction of endogenous and adventitious viral contaminants.

Virus Filtration Market, By End-User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organizations
• Academic Research Institutes
• Medical Device Companies

Based on End-user, the global virus filtration market is segmented into pharmaceutical & biotechnology companies, contract research organizations, academic research institutes, and medical device companies. Pharmaceutical & Biotechnology Companies accounted for the largest market share in 2020, and is projected to grow at a CAGR of 11.64% during the forecast period. The increasing geriatric population and the rising majority of chronic medical disorders positively impact the market growth. Also, the growing need for potential therapies and vaccines to treat patients in critical conditions using viral filtration in convalescent plasma to minimize inflammatory mediators. The continued advancement of bioprocessing technologies such as disposable devices, perfusion reactors, and chromatographic resins increases the global demand for pharmaceutical & biotechnology companies.

Virus Filtration Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world.
• On the basis of regional analysis, the Global Virus filtration Market is classified into North America, Europe, Asia Pacific and Rest of the world, North America accounted for the largest market share in 2021, and is projected to grow at the highest CAGR during the forecast period. The viral filtration industry in North America continued to hold a significant market share in comparison to the other regions. As the region's leading position, particularly in the United States, to follow automation in healthcare procedures. Moreover, the automation of filtration systems has enabled different ancillaries to assist its expansion, as the region contains several well-known firms. Europe was the second-largest market in 2021, and it is projected to grow at a CAGR.

Key Players

• The major players in the Virus Filtration Market are:
• Merck & Co.
• GE Healthcare
• Thermo Fisher Scientific Inc.
• Lonza Group Ltd.
• Pall Corporation
• Charles River Laboratories
• Sartorius AG
• Asahi Kasei Medical Co., Ltd.
• WuXi AppTec

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL VIRUS FILTRATION MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL VIRUS FILTRATION MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis
• 4.5 Regulatory Framework

5 GLOBAL VIRUS FILTRATION MARKET, BY APPLICATION

• 5.1 Medical Devices
• 5.2 Water Purification
• 5.3 Air Purification
• 5.4 Biologicals
  • 5.4.1 Vaccines and Therapeutics
  • 5.4.2 Blood and Blood Products
  • 5.4.3 Cellular and Gene Therapy Products
  • 5.4.4 Others

6 GLOBAL VIRUS FILTRATION MARKET, BY PRODUCT

• 6.1 Kits and Reagents
• 6.2 Filtration Systems
• 6.3 Services
• 6.4 Other Products

7 GLOBAL VIRUS FILTRATION MARKET, BY END USER

• 7.1 Pharmaceutical & Biotechnology Companies
• 7.2 Contract Research Organizations
• 7.3 Academic Research Institutes
• 7.4 Medical Device Companies

8 GLOBAL VIRUS FILTRATION MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Argentina
• 8.6 Rest of the World

9 GLOBAL VIRUS FILTRATION MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Share
• 9.3 Vendor Landscape
• 9.4 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Merck & Co.
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 GE Healthcare
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Thermo Fisher Scientific, Inc.
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Lonza Group Ltd.
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Sartorius AG
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Asahi Kasei Medical Co., Ltd.
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Development
• 10.7 WuXi AppTec
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Development
• 10.8 Pall Corporation
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Charles River Laboratories
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments

11 Appendix

• 11.1 Related Research